Synthesis and biological evaluation of
2‐benzylaminoquinazolin
‐4(
3
H
)‐one derivatives as a potential treatment for
SARS‐CoV
‐2
release_j5xilyl2yfckxojuzzxtflw3ky
by
Jun Young Lee,
Young Sup Shin,
Sangeun Jeon,
Se In Lee,
Jung‐Eun Cho,
Subeen Myung,
Min Seong Jang,
Seungtaek Kim,
Jong Hwan Song,
Hyoung Rae Kim,
Chul Min Park
2022 Volume 43, Issue 3, p412-416
Abstract
Despite the continuing global crisis caused by coronavirus disease 2019 (COVID-19), there is still no effective treatment. Therefore, we designed and synthesized a novel series of 2-benzylaminoquinazolin-4(3H)-one derivatives and demonstrated that they are effective against SARS-CoV-2. Among the synthesized derivatives, 7-chloro-2-(((4-chlorophenyl)(phenyl)methyl)amino)quinazolin-4(3H)-one (Compound 39) showed highest anti-SARS-CoV-2 activity, with a half-maximal inhibitory concentration value greater than that of remdesivir (IC50 = 4.2 μM vs. 7.6 μM, respectively), which gained urgent approval from the U.S. Food and Drug Administration. In addition, Compound 39 showed good results in various assays measuring metabolic stability, human ether a-go-go, Cytochromes P450 (CYPs) inhibition, and plasma protein binding (PPB), and showed better solubility and pharmacokinetics than our previous work.
In text/plain
format
Archived Files and Locations
application/pdf
451.7 kB
file_zoi6cgya2facjovjwrpvke6oce
|
onlinelibrary.wiley.com (publisher) web.archive.org (webarchive) |
Open Access Publication
Not in DOAJ
In ISSN ROAD
In Keepers Registry
ISSN-L:
0253-2964
access all versions, variants, and formats of this works (eg, pre-prints)
Crossref Metadata (via API)
Worldcat
SHERPA/RoMEO (journal policies)
wikidata.org
CORE.ac.uk
Semantic Scholar
Google Scholar